3.25.4 html 190 443 1 true 65 0 false 4 false false R1.htm 000 - Document - Document And Entity Information Sheet http://www.anikatherapeutics.com/20251231/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Condensed Consolidated Balance Sheets Sheet http://www.anikatherapeutics.com/20251231/role/statement-condensed-consolidated-balance-sheets- Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 002 - Statement - Condensed Consolidated Balance Sheets (Parentheticals) Sheet http://www.anikatherapeutics.com/20251231/role/statement-condensed-consolidated-balance-sheets-parentheticals Condensed Consolidated Balance Sheets (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) Sheet http://www.anikatherapeutics.com/20251231/role/statement-condensed-consolidated-statements-of-operations-and-comprehensive-income-loss- Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) Statements 4 false false R5.htm 004 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Unaudited) Sheet http://www.anikatherapeutics.com/20251231/role/statement-condensed-consolidated-statements-of-stockholders-equity-unaudited- Condensed Consolidated Statements of Stockholders' Equity (Unaudited) Statements 5 false false R6.htm 005 - Statement - Condensed Consolidated Statements of Cash Flows Sheet http://www.anikatherapeutics.com/20251231/role/statement-condensed-consolidated-statements-of-cash-flows- Condensed Consolidated Statements of Cash Flows Statements 6 false false R7.htm 995443 - Disclosure - Award Timing Disclosure Sheet http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure Award Timing Disclosure Notes 7 false false R8.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 8 false false R9.htm 995447 - Disclosure - Insider Trading Policies and Procedures Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc Insider Trading Policies and Procedures Notes 9 false false R10.htm 995550 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure Sheet http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure Cybersecurity Risk Management and Strategy Disclosure Notes 10 false false R11.htm 995550 - Disclosure - Note 1 - Nature of Business Sheet http://www.anikatherapeutics.com/20251231/role/statement-note-1-nature-of-business Note 1 - Nature of Business Notes 11 false false R12.htm 995551 - Disclosure - Note 2 - Summary of Significant Accounting Policies Sheet http://www.anikatherapeutics.com/20251231/role/statement-note-2-summary-of-significant-accounting-policies Note 2 - Summary of Significant Accounting Policies Notes 12 false false R13.htm 995552 - Disclosure - Note 3 - Discontinued Operations Sheet http://www.anikatherapeutics.com/20251231/role/statement-note-3-discontinued-operations Note 3 - Discontinued Operations Notes 13 false false R14.htm 995553 - Disclosure - Note 4 - Fair Value Measurements Sheet http://www.anikatherapeutics.com/20251231/role/statement-note-4-fair-value-measurements Note 4 - Fair Value Measurements Notes 14 false false R15.htm 995554 - Disclosure - Note 5 - Inventories Sheet http://www.anikatherapeutics.com/20251231/role/statement-note-5-inventories Note 5 - Inventories Notes 15 false false R16.htm 995555 - Disclosure - Note 6 - Property and Equipment Sheet http://www.anikatherapeutics.com/20251231/role/statement-note-6-property-and-equipment Note 6 - Property and Equipment Notes 16 false false R17.htm 995556 - Disclosure - Note 7 - Acquired Intangible Assets, Net Sheet http://www.anikatherapeutics.com/20251231/role/statement-note-7-acquired-intangible-assets-net Note 7 - Acquired Intangible Assets, Net Notes 17 false false R18.htm 995557 - Disclosure - Note 8 - Goodwill Sheet http://www.anikatherapeutics.com/20251231/role/statement-note-8-goodwill Note 8 - Goodwill Notes 18 false false R19.htm 995558 - Disclosure - Note 9 - Leases Sheet http://www.anikatherapeutics.com/20251231/role/statement-note-9-leases Note 9 - Leases Notes 19 false false R20.htm 995559 - Disclosure - Note 10 - Accrued Expenses Sheet http://www.anikatherapeutics.com/20251231/role/statement-note-10-accrued-expenses Note 10 - Accrued Expenses Notes 20 false false R21.htm 995560 - Disclosure - Note 11 - Revolving Credit Agreement Sheet http://www.anikatherapeutics.com/20251231/role/statement-note-11-revolving-credit-agreement Note 11 - Revolving Credit Agreement Notes 21 false false R22.htm 995561 - Disclosure - Note 12 - Commitments and Contingencies Sheet http://www.anikatherapeutics.com/20251231/role/statement-note-12-commitments-and-contingencies Note 12 - Commitments and Contingencies Notes 22 false false R23.htm 995562 - Disclosure - Note 13 - Revenue and Geographic Information Sheet http://www.anikatherapeutics.com/20251231/role/statement-note-13-revenue-and-geographic-information Note 13 - Revenue and Geographic Information Notes 23 false false R24.htm 995563 - Disclosure - Note 14 - Equity Incentive Plans Sheet http://www.anikatherapeutics.com/20251231/role/statement-note-14-equity-incentive-plans Note 14 - Equity Incentive Plans Notes 24 false false R25.htm 995564 - Disclosure - Note 15 - Employee Benefit Plan Sheet http://www.anikatherapeutics.com/20251231/role/statement-note-15-employee-benefit-plan- Note 15 - Employee Benefit Plan Notes 25 false false R26.htm 995565 - Disclosure - Note 16 - Share Repurchase Sheet http://www.anikatherapeutics.com/20251231/role/statement-note-16-share-repurchase Note 16 - Share Repurchase Notes 26 false false R27.htm 995566 - Disclosure - Note 17 - Income Taxes Sheet http://www.anikatherapeutics.com/20251231/role/statement-note-17-income-taxes Note 17 - Income Taxes Notes 27 false false R28.htm 995567 - Disclosure - Note 18 - Earnings Per Share ("EPS") Sheet http://www.anikatherapeutics.com/20251231/role/statement-note-18-earnings-per-share-eps Note 18 - Earnings Per Share ("EPS") Notes 28 false false R29.htm 995568 - Disclosure - Note 19 - Segment Information Sheet http://www.anikatherapeutics.com/20251231/role/statement-note-19-segment-information Note 19 - Segment Information Notes 29 false false R30.htm 995569 - Disclosure - Significant Accounting Policies (Policies) Sheet http://www.anikatherapeutics.com/20251231/role/statement-significant-accounting-policies-policies Significant Accounting Policies (Policies) Policies http://www.anikatherapeutics.com/20251231/role/statement-note-2-summary-of-significant-accounting-policies 30 false false R31.htm 995570 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Tables) Sheet http://www.anikatherapeutics.com/20251231/role/statement-note-2-summary-of-significant-accounting-policies-tables Note 2 - Summary of Significant Accounting Policies (Tables) Tables http://www.anikatherapeutics.com/20251231/role/statement-note-2-summary-of-significant-accounting-policies 31 false false R32.htm 995571 - Disclosure - Note 3 - Discontinued Operations (Tables) Sheet http://www.anikatherapeutics.com/20251231/role/statement-note-3-discontinued-operations-tables Note 3 - Discontinued Operations (Tables) Tables http://www.anikatherapeutics.com/20251231/role/statement-note-3-discontinued-operations 32 false false R33.htm 995572 - Disclosure - Note 4 - Fair Value Measurements (Tables) Sheet http://www.anikatherapeutics.com/20251231/role/statement-note-4-fair-value-measurements-tables Note 4 - Fair Value Measurements (Tables) Tables http://www.anikatherapeutics.com/20251231/role/statement-note-4-fair-value-measurements 33 false false R34.htm 995573 - Disclosure - Note 5 - Inventories (Tables) Sheet http://www.anikatherapeutics.com/20251231/role/statement-note-5-inventories-tables Note 5 - Inventories (Tables) Tables http://www.anikatherapeutics.com/20251231/role/statement-note-5-inventories 34 false false R35.htm 995574 - Disclosure - Note 6 - Property and Equipment (Tables) Sheet http://www.anikatherapeutics.com/20251231/role/statement-note-6-property-and-equipment-tables Note 6 - Property and Equipment (Tables) Tables http://www.anikatherapeutics.com/20251231/role/statement-note-6-property-and-equipment 35 false false R36.htm 995575 - Disclosure - Note 7 - Acquired Intangible Assets, Net (Tables) Sheet http://www.anikatherapeutics.com/20251231/role/statement-note-7-acquired-intangible-assets-net-tables Note 7 - Acquired Intangible Assets, Net (Tables) Tables http://www.anikatherapeutics.com/20251231/role/statement-note-7-acquired-intangible-assets-net 36 false false R37.htm 995576 - Disclosure - Note 8 - Goodwill (Tables) Sheet http://www.anikatherapeutics.com/20251231/role/statement-note-8-goodwill-tables Note 8 - Goodwill (Tables) Tables http://www.anikatherapeutics.com/20251231/role/statement-note-8-goodwill 37 false false R38.htm 995577 - Disclosure - Note 9 - Leases (Tables) Sheet http://www.anikatherapeutics.com/20251231/role/statement-note-9-leases-tables Note 9 - Leases (Tables) Tables http://www.anikatherapeutics.com/20251231/role/statement-note-9-leases 38 false false R39.htm 995578 - Disclosure - Note 10 - Accrued Expenses (Tables) Sheet http://www.anikatherapeutics.com/20251231/role/statement-note-10-accrued-expenses-tables Note 10 - Accrued Expenses (Tables) Tables http://www.anikatherapeutics.com/20251231/role/statement-note-10-accrued-expenses 39 false false R40.htm 995579 - Disclosure - Note 13 - Revenue and Geographic Information (Tables) Sheet http://www.anikatherapeutics.com/20251231/role/statement-note-13-revenue-and-geographic-information-tables Note 13 - Revenue and Geographic Information (Tables) Tables http://www.anikatherapeutics.com/20251231/role/statement-note-13-revenue-and-geographic-information 40 false false R41.htm 995580 - Disclosure - Note 14 - Equity Incentive Plans (Tables) Sheet http://www.anikatherapeutics.com/20251231/role/statement-note-14-equity-incentive-plans-tables Note 14 - Equity Incentive Plans (Tables) Tables http://www.anikatherapeutics.com/20251231/role/statement-note-14-equity-incentive-plans 41 false false R42.htm 995581 - Disclosure - Note 17 - Income Taxes (Tables) Sheet http://www.anikatherapeutics.com/20251231/role/statement-note-17-income-taxes-tables Note 17 - Income Taxes (Tables) Tables http://www.anikatherapeutics.com/20251231/role/statement-note-17-income-taxes 42 false false R43.htm 995582 - Disclosure - Note 19 - Segment Information (Tables) Sheet http://www.anikatherapeutics.com/20251231/role/statement-note-19-segment-information-tables Note 19 - Segment Information (Tables) Tables http://www.anikatherapeutics.com/20251231/role/statement-note-19-segment-information 43 false false R44.htm 995583 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Details Textual) Sheet http://www.anikatherapeutics.com/20251231/role/statement-note-2-summary-of-significant-accounting-policies-details-textual Note 2 - Summary of Significant Accounting Policies (Details Textual) Details http://www.anikatherapeutics.com/20251231/role/statement-note-2-summary-of-significant-accounting-policies-tables 44 false false R45.htm 995584 - Disclosure - Note 2 - Summary of Significant Accounting Policies - Allowance for Doubtful Accounts (Details) Sheet http://www.anikatherapeutics.com/20251231/role/statement-note-2-summary-of-significant-accounting-policies-allowance-for-doubtful-accounts-details Note 2 - Summary of Significant Accounting Policies - Allowance for Doubtful Accounts (Details) Details 45 false false R46.htm 995585 - Disclosure - Note 2 - Summary of Significant Accounting Policies - Schedule Of Property Plant and Equipment (Details) Sheet http://www.anikatherapeutics.com/20251231/role/statement-note-2-summary-of-significant-accounting-policies-schedule-of-property-plant-and-equipment-details Note 2 - Summary of Significant Accounting Policies - Schedule Of Property Plant and Equipment (Details) Details 46 false false R47.htm 995586 - Disclosure - Note 3 - Discontinued Operations (Details Textual) Sheet http://www.anikatherapeutics.com/20251231/role/statement-note-3-discontinued-operations-details-textual Note 3 - Discontinued Operations (Details Textual) Details http://www.anikatherapeutics.com/20251231/role/statement-note-3-discontinued-operations-tables 47 false false R48.htm 995587 - Disclosure - Note 3 - Discontinued Operations - Schedule Of Discontinued Operations (Details) Sheet http://www.anikatherapeutics.com/20251231/role/statement-note-3-discontinued-operations-schedule-of-discontinued-operations-details Note 3 - Discontinued Operations - Schedule Of Discontinued Operations (Details) Details 48 false false R49.htm 995588 - Disclosure - Note 4 - Fair Value Measurements (Details Textual) Sheet http://www.anikatherapeutics.com/20251231/role/statement-note-4-fair-value-measurements-details-textual Note 4 - Fair Value Measurements (Details Textual) Details http://www.anikatherapeutics.com/20251231/role/statement-note-4-fair-value-measurements-tables 49 false false R50.htm 995589 - Disclosure - Note 4 - Fair Value Measurements - Fair Value of Financial Instruments (Details) Sheet http://www.anikatherapeutics.com/20251231/role/statement-note-4-fair-value-measurements-fair-value-of-financial-instruments-details Note 4 - Fair Value Measurements - Fair Value of Financial Instruments (Details) Details 50 false false R51.htm 995590 - Disclosure - Note 5 - Inventories (Details Textual) Sheet http://www.anikatherapeutics.com/20251231/role/statement-note-5-inventories-details-textual Note 5 - Inventories (Details Textual) Details http://www.anikatherapeutics.com/20251231/role/statement-note-5-inventories-tables 51 false false R52.htm 995591 - Disclosure - Note 5 - Inventories - Summary of Inventories (Details) Sheet http://www.anikatherapeutics.com/20251231/role/statement-note-5-inventories-summary-of-inventories-details Note 5 - Inventories - Summary of Inventories (Details) Details 52 false false R53.htm 995592 - Disclosure - Note 6 - Property and Equipment (Details Textual) Sheet http://www.anikatherapeutics.com/20251231/role/statement-note-6-property-and-equipment-details-textual Note 6 - Property and Equipment (Details Textual) Details http://www.anikatherapeutics.com/20251231/role/statement-note-6-property-and-equipment-tables 53 false false R54.htm 995593 - Disclosure - Note 6 - Property and Equipment - Property and Equipment at Cost (Details) Sheet http://www.anikatherapeutics.com/20251231/role/statement-note-6-property-and-equipment-property-and-equipment-at-cost-details Note 6 - Property and Equipment - Property and Equipment at Cost (Details) Details 54 false false R55.htm 995594 - Disclosure - Note 7 - Acquired Intangible Assets, Net (Details Textual) Sheet http://www.anikatherapeutics.com/20251231/role/statement-note-7-acquired-intangible-assets-net-details-textual Note 7 - Acquired Intangible Assets, Net (Details Textual) Details http://www.anikatherapeutics.com/20251231/role/statement-note-7-acquired-intangible-assets-net-tables 55 false false R56.htm 995595 - Disclosure - Note 7 - Acquired Intangible Assets, Net - Summary of Intangible Assets (Details) Sheet http://www.anikatherapeutics.com/20251231/role/statement-note-7-acquired-intangible-assets-net-summary-of-intangible-assets-details Note 7 - Acquired Intangible Assets, Net - Summary of Intangible Assets (Details) Details 56 false false R57.htm 995596 - Disclosure - Note 8 - Goodwill - Changes in the Carrying Value of Goodwill (Details) Sheet http://www.anikatherapeutics.com/20251231/role/statement-note-8-goodwill-changes-in-the-carrying-value-of-goodwill-details Note 8 - Goodwill - Changes in the Carrying Value of Goodwill (Details) Details 57 false false R58.htm 995597 - Disclosure - Note 9 - Leases (Details Textual) Sheet http://www.anikatherapeutics.com/20251231/role/statement-note-9-leases-details-textual Note 9 - Leases (Details Textual) Details http://www.anikatherapeutics.com/20251231/role/statement-note-9-leases-tables 58 false false R59.htm 995598 - Disclosure - Note 9 - Leases - Lease Expense and Other Information (Details) Sheet http://www.anikatherapeutics.com/20251231/role/statement-note-9-leases-lease-expense-and-other-information-details Note 9 - Leases - Lease Expense and Other Information (Details) Details 59 false false R60.htm 995599 - Disclosure - Note 9 - Leases - Future Minimum Rental Payments for Leases (Details) Sheet http://www.anikatherapeutics.com/20251231/role/statement-note-9-leases-future-minimum-rental-payments-for-leases-details Note 9 - Leases - Future Minimum Rental Payments for Leases (Details) Details 60 false false R61.htm 995600 - Disclosure - Note 10 - Accrued Expenses - Summary of Accrued Expenses (Details) Sheet http://www.anikatherapeutics.com/20251231/role/statement-note-10-accrued-expenses-summary-of-accrued-expenses-details Note 10 - Accrued Expenses - Summary of Accrued Expenses (Details) Details 61 false false R62.htm 995601 - Disclosure - Note 11 - Revolving Credit Agreement (Details Textual) Sheet http://www.anikatherapeutics.com/20251231/role/statement-note-11-revolving-credit-agreement-details-textual Note 11 - Revolving Credit Agreement (Details Textual) Details http://www.anikatherapeutics.com/20251231/role/statement-note-11-revolving-credit-agreement 62 false false R63.htm 995602 - Disclosure - Note 12 - Commitments and Contingencies (Details Textual) Sheet http://www.anikatherapeutics.com/20251231/role/statement-note-12-commitments-and-contingencies-details-textual Note 12 - Commitments and Contingencies (Details Textual) Details http://www.anikatherapeutics.com/20251231/role/statement-note-12-commitments-and-contingencies 63 false false R64.htm 995603 - Disclosure - Note 13 - Revenue and Geographic Information (Details Textual) Sheet http://www.anikatherapeutics.com/20251231/role/statement-note-13-revenue-and-geographic-information-details-textual Note 13 - Revenue and Geographic Information (Details Textual) Details http://www.anikatherapeutics.com/20251231/role/statement-note-13-revenue-and-geographic-information-tables 64 false false R65.htm 995604 - Disclosure - Note 13 - Revenue and Geographic Information - Disaggregated Revenues (Details) Sheet http://www.anikatherapeutics.com/20251231/role/statement-note-13-revenue-and-geographic-information-disaggregated-revenues-details Note 13 - Revenue and Geographic Information - Disaggregated Revenues (Details) Details 65 false false R66.htm 995605 - Disclosure - Note 13 - Revenue and Geographic Information - Total Revenue by Geographic Location (Details) Sheet http://www.anikatherapeutics.com/20251231/role/statement-note-13-revenue-and-geographic-information-total-revenue-by-geographic-location-details Note 13 - Revenue and Geographic Information - Total Revenue by Geographic Location (Details) Details 66 false false R67.htm 995606 - Disclosure - Note 13 - Revenue and Geographic Information - Net Tangible Long-lived Assets by Principal Geographic Areas (Details) Sheet http://www.anikatherapeutics.com/20251231/role/statement-note-13-revenue-and-geographic-information-net-tangible-longlived-assets-by-principal-geographic-areas-details Note 13 - Revenue and Geographic Information - Net Tangible Long-lived Assets by Principal Geographic Areas (Details) Details 67 false false R68.htm 995607 - Disclosure - Note 14 - Equity Incentive Plans (Details Textual) Sheet http://www.anikatherapeutics.com/20251231/role/statement-note-14-equity-incentive-plans-details-textual Note 14 - Equity Incentive Plans (Details Textual) Details http://www.anikatherapeutics.com/20251231/role/statement-note-14-equity-incentive-plans-tables 68 false false R69.htm 995608 - Disclosure - Note 14 - Equity Incentive Plan - Total Stock-based Compensation Expense (Details) Sheet http://www.anikatherapeutics.com/20251231/role/statement-note-14-equity-incentive-plan-total-stockbased-compensation-expense-details Note 14 - Equity Incentive Plan - Total Stock-based Compensation Expense (Details) Details 69 false false R70.htm 995609 - Disclosure - Note 14 - Equity Incentive Plan - Stock Options (Details) Sheet http://www.anikatherapeutics.com/20251231/role/statement-note-14-equity-incentive-plan-stock-options-details Note 14 - Equity Incentive Plan - Stock Options (Details) Details 70 false false R71.htm 995610 - Disclosure - Note 14 - Equity Incentive Plan - Assumptions Used to Estimate Fair Value of Stock Options and Stock Appreciation Rights (Details) Sheet http://www.anikatherapeutics.com/20251231/role/statement-note-14-equity-incentive-plan-assumptions-used-to-estimate-fair-value-of-stock-options-and-stock-appreciation-rights-details Note 14 - Equity Incentive Plan - Assumptions Used to Estimate Fair Value of Stock Options and Stock Appreciation Rights (Details) Details 71 false false R72.htm 995611 - Disclosure - Note 14 - Equity Incentive Plan - Schedule of Restricted Stock Activity (Details) Sheet http://www.anikatherapeutics.com/20251231/role/statement-note-14-equity-incentive-plan-schedule-of-restricted-stock-activity-details Note 14 - Equity Incentive Plan - Schedule of Restricted Stock Activity (Details) Details 72 false false R73.htm 995612 - Disclosure - Note 14 - Equity Incentive Plan - Schedule of Performance Share Units (Details) Sheet http://www.anikatherapeutics.com/20251231/role/statement-note-14-equity-incentive-plan-schedule-of-performance-share-units-details Note 14 - Equity Incentive Plan - Schedule of Performance Share Units (Details) Details 73 false false R74.htm 995613 - Disclosure - Note 15 - Employee Benefit Plan (Details Textual) Sheet http://www.anikatherapeutics.com/20251231/role/statement-note-15-employee-benefit-plan-details-textual Note 15 - Employee Benefit Plan (Details Textual) Details http://www.anikatherapeutics.com/20251231/role/statement-note-15-employee-benefit-plan- 74 false false R75.htm 995614 - Disclosure - Note 16 - Share Repurchase (Details Textual) Sheet http://www.anikatherapeutics.com/20251231/role/statement-note-16-share-repurchase-details-textual Note 16 - Share Repurchase (Details Textual) Details http://www.anikatherapeutics.com/20251231/role/statement-note-16-share-repurchase 75 false false R76.htm 995615 - Disclosure - Note 17 - Income Taxes (Details Textual) Sheet http://www.anikatherapeutics.com/20251231/role/statement-note-17-income-taxes-details-textual Note 17 - Income Taxes (Details Textual) Details http://www.anikatherapeutics.com/20251231/role/statement-note-17-income-taxes-tables 76 false false R77.htm 995616 - Disclosure - Note 17 - Income Taxes - Components of Income Before Taxes and Provision for (Benefit from) Income Taxes (Details) Sheet http://www.anikatherapeutics.com/20251231/role/statement-note-17-income-taxes-components-of-income-before-taxes-and-provision-for-benefit-from-income-taxes-details Note 17 - Income Taxes - Components of Income Before Taxes and Provision for (Benefit from) Income Taxes (Details) Details 77 false false R78.htm 995617 - Disclosure - Note 17 - Income Taxes - Significant Components of Company's Deferred Tax Assets and Liabilities (Details) Sheet http://www.anikatherapeutics.com/20251231/role/statement-note-17-income-taxes-significant-components-of-companys-deferred-tax-assets-and-liabilities-details Note 17 - Income Taxes - Significant Components of Company's Deferred Tax Assets and Liabilities (Details) Details 78 false false R79.htm 995618 - Disclosure - Note 17 - Income Taxes - Reconciliation Between U.S. Federal Statutory Rate and Effective Rate (Details) Sheet http://www.anikatherapeutics.com/20251231/role/statement-note-17-income-taxes-reconciliation-between-us-federal-statutory-rate-and-effective-rate-details Note 17 - Income Taxes - Reconciliation Between U.S. Federal Statutory Rate and Effective Rate (Details) Details 79 false false R80.htm 995619 - Disclosure - Note 17 - Income Taxes - Schedule of Income Taxes Paid (Details) Sheet http://www.anikatherapeutics.com/20251231/role/statement-note-17-income-taxes-schedule-of-income-taxes-paid-details Note 17 - Income Taxes - Schedule of Income Taxes Paid (Details) Details 80 false false R81.htm 995620 - Disclosure - Note 19 - Segment Information (Details Textual) Sheet http://www.anikatherapeutics.com/20251231/role/statement-note-19-segment-information-details-textual Note 19 - Segment Information (Details Textual) Details http://www.anikatherapeutics.com/20251231/role/statement-note-19-segment-information-tables 81 false false R82.htm 995621 - Disclosure - Note 19 - Segment Information - Summary Of Segment Information (Details) Sheet http://www.anikatherapeutics.com/20251231/role/statement-note-19-segment-information-summary-of-segment-information-details Note 19 - Segment Information - Summary Of Segment Information (Details) Details 82 false false All Reports Book All Reports anik-20251231.xsd anik-20251231_cal.xml anik-20251231_def.xml anik-20251231_lab.xml anik-20251231_pre.xml anik20251231_10k.htm keyprod.jpg perf.jpg http://fasb.org/srt/2025 http://fasb.org/us-gaap/2025 http://xbrl.sec.gov/cyd/2025 http://xbrl.sec.gov/dei/2025 http://xbrl.sec.gov/ecd/2025 true true